Cite
MLA Citation
M. Carducci et al.. “4BA A phase 3, randomized, double-blind, placebo-controlled study of tasquinimod (TASQ) in men with metastatic castrate resistant prostate cancer (mCRPC).” European journal of cancer, vol. 51, n.d., pp. S713–S714. http://access.bl.uk/ark:/81055/vdc_100030687872.0x000042